(Q51824419)
Statements
1 reference
A controlled trial of 6-weeks' treatment with a novel inhaled phosphodiesterase type-4 inhibitor in COPD. (English)
1 reference
L Tan
1 reference
G Atkinson
1 reference
J Ward
1 reference
UK-500,001 Global Study Team
1 reference
12 February 2009
1 reference
33
1 reference
5
1 reference
1039-1044
1 reference
Identifiers
1 reference